News Sentiment

CRTX sentiment intelligence

CRISM Therapeutics Corporation news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 50 Balanced news tone 5 relevant articles
Exchange LSE United Kingdom
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 0.10 Week of 10 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

82/100 classification confidence.

Company focus 5

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-2.4% over one week, -2.4% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Crism completes manufacture of first ChemoSeed chemical batch

Market Reaction

Balanced read

59/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 82/100 classification
One-week reaction -2.4% Price reacting lower
Trend fit Trend inactive -2.4% over four weeks
Fair value -20.0% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 0
Neutral 5
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 5
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Sharecast.com 2
Market source 1
TradingView 1
MarketBeat 1

Event Lens

What the news is about

Classified themes
Market update 5

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-5 of 5